E
Sell
1/26/2024Downgrade
InnoCan Pharma Corporation (INNO) was downgraded to E+ from D- on 1/26/2024 due to a decline in the total return index and volatility index.
D
Sell
11/30/2023Upgraded
InnoCan Pharma Corporation (INNO) was upgraded to D- from E+ on 11/30/2023 due to a noticeable increase in the total return index, volatility index and valuation index.
E
Sell
3/14/2023Downgrade
InnoCan Pharma Corporation (INNO) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index and total return index.
D
Sell
2/9/2023Upgraded
InnoCan Pharma Corporation (INNO) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
InnoCan Pharma Corporation (INNO) was downgraded to E+ from D on 2/8/2023 due to a large decline in the total return index, volatility index and solvency index.
D
Sell
5/5/2022Upgraded
InnoCan Pharma Corporation (INNO) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index.
D
Sell
4/20/2022Downgrade
InnoCan Pharma Corporation (INNO) was downgraded to D- from D on 4/20/2022 due to a noticeable decline in the total return index, volatility index and growth index. Operating cash flow declined 74.61% from -$1.35M to -$2.35M, total revenue declined 70.37% from $54 to $16, and EBIT declined 58.37% from -$1.62M to -$2.57M.
D
Sell
11/3/2021Upgraded
InnoCan Pharma Corporation (INNO) was upgraded to D from D- on 11/3/2021 due to a large increase in the total return index, solvency index and growth index. Total revenue increased 140.54% from $37 to $89, earnings per share increased from -$0.024 to -$0.005, and EBIT increased 52.08% from -$2.26M to -$1.08M.
D
Sell
7/1/2021Upgraded
InnoCan Pharma Corporation (INNO) was upgraded to D- from E+ on 7/1/2021 due to an increase in the valuation index and total return index.
E
Sell
4/1/2021Upgraded
InnoCan Pharma Corporation (INNO) was upgraded to E+ from E on 4/1/2021 due to a major increase in the total return index.
E
Sell
12/29/2020None
InnoCan Pharma Corporation (INNO) was downgraded to E from U on 12/29/2020.
